in

Dual SGLT1/2 Inhibitor Protects Against MI and Stroke

Source link : https://newshealth.biz/health-news/dual-sglt1-2-inhibitor-protects-against-mi-and-stroke/

The dual sodium-glucose cotransporter 1 and 2 (SGLT1/2) inhibitor sotagliflozin reduced major adverse cardiovascular events, with significant reductions in the individual outcomes of myocardial infarction (MI) and stroke in patients with type 2 diabetes, chronic kidney disease, and other cardiovascular risk factors in a prespecified secondary analysis of the SCORED trial. This ischemic benefit of […]

Author : News Health

Publish date : 2025-02-27 12:09:11

Copyright for syndicated content belongs to the linked Source.

La Junta cancela el uso turístico de casi 1.500 viviendas de Cádiz, Granada, Málaga y Sevilla por no cumplir con la normativa

Trump’s international support freeze halted a an important program combating HIV in Africa. Here is what’s at stake – ABC Information